World's Best Scientists 2026 revealed!
Klaus-Michael Debatin

Klaus-Michael Debatin

Award Badge
Biology and Biochemistry
Germany
2023

D-Index & Metrics

Medicine

D-Index
117
Citations
68011
World Ranking
4131
National Ranking
227

Klaus-Michael Debatin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Klaus-Michael Debatin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 742 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Klaus-Michael Debatin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus-Michael Debatin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Germany Leader Award

Overview

Klaus-Michael Debatin is affiliated with the University of Ulm in Germany and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans multiple subfields including molecular biology, immunology, infectious diseases, genetics, and neurology.

The scientist's recent published papers include:

  • Apoptotic cell death in disease-Current understanding of the NCCD, 2023, Cell Death and Differentiation
  • Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany, 2021, JAMA Pediatrics
  • Robust and durable serological response following pediatric SARS-CoV-2 infection, 2022, Nature Communications
  • Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma, 2020, British Journal of Cancer
  • Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56brightCD16+NKp80+/-In-Vitro and Express KIR2DL2/DL3 and KIR3DL1, 2021, Frontiers in Immunology

Frequent co-authors of Klaus-Michael Debatin include:

  • Pamela Fischer-Posovszky
  • Aleš Janda
  • Eva-Maria Jacobsen
  • Mike-Andrew Westhoff
  • Felix Seyfried

They publish regularly in several journals, with the most frequent publication venues being:

  • Blood
  • Klinische Pädiatrie
  • Oncogene
  • Cancer Research
  • Leukemia

Main fields of study are Medicine and Biochemistry, Genetics and Molecular Biology, supported by a focus on subfields such as molecular biology, immunology, infectious diseases, genetics, and neurology.

The primary topics of their research include:

  • Acute Lymphoblastic Leukemia research
  • Neuroblastoma Research and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Cell death mechanisms and regulation
  • COVID-19 Clinical Research Studies
  • MicroRNA in disease regulation
  • Glioma Diagnosis and Treatment

Best Publications

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Two CD95 (APO-1/Fas) signaling pathways

    Carsten Scaffidi;Simone Fulda;Anu Srinivasan;Claudia Friesen

  • Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy.

    S. Fulda;Klaus-Michael Debatin

  • Monoclonal antibody-mediated tumor regression by induction of apoptosis

    Bernhard C. Trauth;Christiane Klas;Anke M.J. Peters;Siegfried Matzku

  • Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

    Jens Dhein;Henning Walczak;Caroline Bäumler;Klaus-Michael Debatin

  • Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

    F. Rieux-Laucat;F. Le Deist;C. Hivroz;I. A. G. Roberts

  • Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.

    Claudia Friesen;Ingrid Herr;Ingrid Herr;Peter H. Krammer;Klaus Michael Debatin;Klaus Michael Debatin

  • Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

    L. Galluzzi;J. M. Bravo-San Pedro;I. Vitale;S. A. Aaronson

  • Cellular stress response and apoptosis in cancer therapy

    Ingrid Herr;Klaus-Michael Debatin

  • Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

    Simone Fulda;Wolfgang Wick;Michael Weller;Klaus Michael Debatin;Klaus Michael Debatin

  • Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

    F. Leithauser;J. Dhein;G. Mechtersheimer;K. Koretz

  • Death receptors in chemotherapy and cancer.

    Klaus Michael Debatin;Peter H. Krammer

  • The CD95 (APO-1/Fas) System Mediates Drug-induced Apoptosis in Neuroblastoma Cells

    Simone Fulda;Hauke Sieverts;Claudia Friesen;Ingrid Herr

  • Activation interferes with the APO-1 pathway in mature human T cells

    Christiane Klas;Klaus michael Debatin;Richard R. Jonker;Richard R. Jonker;Peter H. Krammer

  • Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation

    Wabitsch M;Brenner Re;Melzner I;Braun M

  • Apoptosis pathways in cancer and cancer therapy.

    Klaus-Michael Debatin

  • CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons.

    Ana Martin-Villalba;Ingrid Herr;Irmela Jeremias;Michael Hahne

  • Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

    Simone Fulda;Martin U Küfer;Eric Meyer;Frans van Valen

  • Chemotherapy: targeting the mitochondrial cell death pathway.

    Klaus-Michael Debatin;Delphine Poncet;Guido Kroemer

  • Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

    Simone Fulda;Eric Meyer;Klaus-Michael Debatin

Frequent Co-Authors

Simone Fulda
Simone Fulda Goethe University Frankfurt
Martin Wabitsch
Martin Wabitsch University of Ulm
Peter H. Krammer
Peter H. Krammer German Cancer Research Center
klaus schwarz
klaus schwarz University of Ulm
Irmela Jeremias
Irmela Jeremias Ludwig-Maximilians-Universität München
Dirk Reinhardt
Dirk Reinhardt University of Duisburg-Essen
Thomas F. E. Barth
Thomas F. E. Barth University of Ulm
Henning Walczak
Henning Walczak University College London
Marek Los
Marek Los Silesian University of Technology
Peter Møller
Peter Møller University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees is a great way to advance in the healthcare field while maintaining a flexible schedule. For aspiring nurse practitioners, finding the cheapest nurse practitioner programs can significantly reduce student debt and make career progression more accessible.

Nursing remains one of the most popular healthcare careers, and affordability is often a top concern. Knowing what is the cheapest online college for nursing? helps future students compare tuition rates and select a program that fits their budget.

For registered nurses seeking advanced credentials, doctoral options are available online as well. Researching the cheapest phd nursing programs opens the door to leadership roles and academic careers within nursing.

Many working RNs choose to further their education with an undergraduate degree. Discovering what is the cheapest rn to bsn program online ensures that professional growth doesn’t come at an overwhelming financial cost.

These online pathways offer flexibility, affordability, and the chance to build a rewarding healthcare career.

Best Scientists Citing Klaus-Michael Debatin

Trending Scientists

Recently Published Articles